Komori
Earnings4998FUMAKILLA LIMITEDMaterials and Chemicals

Q1 Financial Results for the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)

For the first quarter of the fiscal year ending March 2027, net sales and operating income exceeded the year-earlier period, while ordinary income and net income attributable to owners of the parent were lower. The full-year earnings forecasts and annual dividend forecast remain unchanged.

Worth reading
30Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
9.6
Year-on-year change in revenue (%)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAP
Net Sales22,815¥ millionYear on year +9.6%Progress 26.9%
Operating profit1,343¥ millionYear on year +7.0%Progress 45.5%
Ordinary income1,219¥ millionYear on year -4.4%Progress 43.4%
Net income attributable to owners of the parent394¥ millionYear on year -25.7%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥23.92
Financial position at period-end
Total assets69,360¥ million
of which net assets 29,604 ¥ millionEquity ratio 39.6%vs. prior year-end +0.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueJapan ¥9,595 million (YoY +8.3%), Southeast Asia ¥9,081 million (YoY +11.8%), Europe ¥3,380 million (YoY +9.2%), Other ¥757 million (YoY +1.5%)
Segment profitJapan ¥150 million (YoY -23.5%), Southeast Asia ¥636 million (YoY +22.1%), Europe ¥199 million (YoY -28.9%), Other ¥118 million (YoY +197.0%)
Regional sales¥9,387 million (YoY +6.9%), ¥13,427 million (YoY +11.5%), ¥22,815 million (YoY +9.6%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥84,800 million (YoY +9.6%)
Operating profit¥2,950 million (YoY +34.7%)
Ordinary income¥2,810 million (YoY +24.1%)
Profit attributable to owners of the parent¥1,630 million (YoY +35.1%)
Revision to Earnings ForecastNot disclosed → Not disclosed
Annual Dividend Forecast¥24 → ¥24(0.0%)
Factors Behind Changes in Business Performance

Net sales increased 9.6% year on year. In Japan, sales of insecticides increased due to favorable weather and new products, while overseas sales increased due to the yen's depreciation. Cost of sales increased by ¥1,360 million, and selling, general and administrative expenses increased 10.0%, mainly because of higher personnel and advertising expenses.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Impairment lossAmount ¥0 million / Subject assets No applicable matters
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of non-current assets / Amount ¥0 million / Extraordinary loss No applicable matters
Depreciation and amortization¥445 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End16,490,000
Treasury Shares at Period-End10,929
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026 to 30 June 2026
Net Sales¥22,815 million (YoY +9.6%)
Operating profit¥1,343 million (YoY +7.0%)
Ordinary income¥1,219 million (YoY -4.4%)
Profit attributable to owners of the parent¥394 million (YoY -25.7%)
Net income per share¥23.92
Equity ratioEnd of the current fiscal period 39.6 / End of previous period 39.1
Total assets¥69,360 million
Net assets¥29,604 million
Full-year earnings forecastNet Sales ¥84,800 million (YoY +9.6%) / Operating profit ¥2,950 million (YoY +34.7%) / Ordinary income ¥2,810 million (YoY +24.1%) / Profit attributable to owners of the parent ¥1,630 million (YoY +35.1%)
Revision to Earnings ForecastNot disclosed → Not disclosed
Annual Dividend Forecast¥24 → ¥24(0.0%)
Segment revenueJapan ¥9,595 million (YoY +8.3%), Southeast Asia ¥9,081 million (YoY +11.8%), Europe ¥3,380 million (YoY +9.2%), Other ¥757 million (YoY +1.5%)
Segment profitJapan ¥150 million (YoY -23.5%), Southeast Asia ¥636 million (YoY +22.1%), Europe ¥199 million (YoY -28.9%), Other ¥118 million (YoY +197.0%)
Regional sales¥9,387 million (YoY +6.9%), ¥13,427 million (YoY +11.5%), ¥22,815 million (YoY +9.6%)
Depreciation and amortization¥445 million
Impairment lossAmount ¥0 million / Subject assets No applicable matters
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of non-current assets / Amount ¥0 million / Extraordinary loss No applicable matters
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End16,490,000
Treasury Shares at Period-End10,929
Factors Behind Changes in Business PerformanceNet sales increased 9.6% year on year. In Japan, sales of insecticides increased due to favorable weather and new products, while overseas sales increased due to the yen's depreciation. Cost of sales increased by ¥1,360 million, and selling, general and administrative expenses increased 10.0%, mainly because of higher personnel and advertising expenses.
Items this document does not state (9)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyOrders received and order backlogMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In Japan, sales of insecticides increased due to favorable weather and the effects of new products, while sales of gardening products and pest-control agents declined. Overseas sales were broadly unchanged in local-currency terms but increased due to the yen's depreciation. Selling, general and administrative expenses increased, mainly because of higher personnel and advertising expenses. No specific reasons were given for the declines in ordinary income and net income.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Q1 Financial Results for the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated) | FUMAKILLA LIMITED (4998) timely disclosure | Komori